CXorf20, or Chromosome X Open Reading Frame 20, is a protein encoded by the CXorf20 gene located on the X chromosome. Despite being cataloged and recognized within the human genome, CXorf20 is a relatively enigmatic protein with limited characterization in the scientific literature. Its function, structure, and involvement in cellular processes are not well-defined, which is not uncommon for proteins annotated through genome sequencing projects without extensive functional studies.From the perspective of bioinformatics, CXorf20 is predicted to have a role based on its gene sequence and the presence of conserved domains when compared to other proteins with known functions. However, without experimental validation, predictions remain speculative. Proteins like CXorf20 often become subjects of interest in research when links to disease states or unique biological pathways are uncovered through genetic association studies or differential expression analyses under specific physiological or pathological conditions.
The presence of CXorf20 in certain tissues or cell types, its expression patterns during development or in response to external stimuli, and potential interacting partners within the cell are all areas that could provide insight into its function. Moreover, as a gene located on the X chromosome, CXorf20 could have implications in sex-specific biology and diseases, considering the unique pattern of inheritance and regulation of X-linked genes.Understanding CXorf20 is also complicated by the fact that many proteins encoded by genes classified as open reading frames (ORFs) do not have well-characterized functions or may represent non-coding sequences that were initially thought to encode proteins. As such, CXorf20 represents a piece of the genomic puzzle that awaits further scientific exploration to reveal its role within the cell and the organism as a whole.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound intercalates into DNA and inhibits RNA polymerase, potentially reducing transcription of the CXorf20 gene. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
It specifically inhibits RNA polymerase II, which could suppress the transcription of CXorf20. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide blocks eukaryotic protein synthesis, possibly decreasing the translation of CXorf20 mRNA. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
This antibiotic causes premature chain termination during translation, potentially lowering CXorf20 protein levels. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine interferes with lysosomal function and pH, which might indirectly affect the processing of CXorf20. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
As a proteasome inhibitor, MG132 might affect the turnover of CXorf20 if it is subject to proteasomal degradation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound is a DNA methyltransferase inhibitor and can lead to changes in gene expression, including CXorf20. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
It inhibits histone deacetylases, thereby affecting chromatin structure and potentially CXorf20 gene expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR signaling pathway, which can lead to altered regulation of protein synthesis, affecting CXorf20. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
This compound affects protein degradation pathways and could influence the stability and expression of CXorf20. | ||||||